Autres langues Microba Life Sciences Limited

Actions

MAP

AU0000209868

Marché Fermé - Australian S.E. Autres places de cotation 02:04:33 30/04/2024			Varia. 5j.	Varia. 1 janv.
0,185 ^AUD	-.--%		+8,82 %	+2,78 %

10/04	Microba Life Sciences obtient un remboursement d'impôt de 6 millions de dollars australiens pour l'exercice 2023 ; les actions chutent de 5 %.	MT
13/03	Les actions australiennes suivent les gains de leurs homologues de Wall Street alors que le marché réagit aux données sur l'inflation américaine	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Microba's Revenue Climbs 297% in Fiscal Q3	23/04
Microba Life Sciences Secures AU$6 Million Tax Rebate for Fiscal Year 2023; Shares Fall 5%	10/04
2,700,000 Options of Microba Life Sciences Limited are subject to a Lock-Up Agreement Ending on 5-APR-2024.	05/04
48,031,314 Ordinary Shares of Microba Life Sciences Limited are subject to a Lock-Up Agreement Ending on 5-APR-2024.	05/04
Australian Shares Track Gains of Wall Street Peers as Market Shrugs Off US Inflation Data	13/03
Microba Life Sciences Rise 9% Following Launch of MetaPanel Test With Sonic Healthcare	13/03
Microba Life Sciences Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02
8,250,000 Options of Microba Life Sciences Limited are subject to a Lock-Up Agreement Ending on 5-FEB-2024.	05/02
54,500,297 Ordinary Shares of Microba Life Sciences Limited are subject to a Lock-Up Agreement Ending on 27-JAN-2024.	27/01
Weak Oil Prices, China's Property Woes Hold Down Australian Shares	07/12
Microba Life Sciences Validates Safety, Tolerability of Inflammatory Bowel Disease Therapy in Phase One Trial	07/12
Microba Life Sciences Completes Acquisition of UK Microbiome Testing Company; Shares Slide 5%	06/12
Microba Life Sciences Limited completed the acquisition of Invivo Clinical Limited.	05/12
Microba Life Sciences Signs Research Agreement with IFF Subsidiary to Develop Allergy Treatments	04/12
Microba Life Sciences' Domestica, International Personal Testing Revenue Rises in Fiscal Q1	19/10/23
Microba Life Sciences to Acquire Invivo Clinical	19/10/23
Microba Life Sciences Limited signed a binding share purchase agreement to acquire Invivo Clinical Limited for £11 million.	19/10/23
Microba Life Sciences Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/08/23
Microba Life Sciences Completes Dosing for Phase One Trial of Biotherapeutic Product	25/08/23
Primer acuerdo de distribución firmado con Sonic Healthcare	05/07/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Microba Life Sciences Limited

Actions

MAP

AU0000209868

Autres langues

Filtres